[{"indications": "Indications\u00a0see under Dose and notes above", "name": "OXYTOCIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.1 Drugs used in obstetrics", "7.1.1 Prostaglandins and oxytocics", "OXYTOCIN"], "cautions": "Cautions\u00a0induction or enhancement of labour\u2014presence of borderline\r\ncephalopelvic disproportion (avoid if significant), secondary\r\nuterine inertia, mild or moderate pregnancy-induced\r\nhypertension or cardiac disease, women over 35 years or with history\r\nof lower-uterine segment caesarean section (see also under Contra-indications\r\nbelow); risk factors for disseminated intravascular coagulation; monitor for disseminated intravascular coagulation\r\nafter parturition; avoid large infusion volumes and\r\nrestrict fluid intake by mouth (risk of hyponatraemia and water-intoxication\u2014see\r\nalso Appendix 4); effects\r\nenhanced by concomitant prostaglandins (very careful\r\nmonitoring of uterine activity); caudal block anaesthesia\r\n(may enhance hypertensive effects of sympathomimetic vasopressors); see also interactions: Appendix 1 (oxytocin)", "side-effects": "Side-effects\u00a0nausea, vomiting; arrhythmia; headache; rarely disseminated intravascular coagulation, rash, and\r\nanaphylactoid reactions (with dyspnoea, hypotension, or shock); uterine\r\nspasm (may occur at low doses), uterine hyperstimulation (usually\r\nwith excessive doses\u2014may cause fetal distress, asphyxia, and death,\r\nor may lead to hypertonicity, tetanic contractions, soft-tissue damage\r\nor uterine rupture); water intoxication and hyponatraemia associated\r\nwith high doses with large infusion volumes of electrolyte-free fluid\r\n(see also under Dose below); placental abruption and amniotic fluid\r\nembolism also reported on overdose", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4501.htm", "doses": ["Induction of labour for medical reasons or stimulation\r\nof labour in hypotonic uterine inertia, by intravenous infusion (not to be started for at least 6 hours after administration of\r\nvaginal prostaglandin), initially 0.001\u20130.004\u00a0units/minute, increased\r\nat intervals of at least 30 minutes until a maximum of 3\u20134 contractions\r\noccur every 10 minutes (0.01\u00a0units/minute is often adequate) up to\r\nmax. 0.02\u00a0units/minute; if regular contractions not established after\r\ntotal of 5\u00a0units stop induction attempt (may be repeated next day\r\nstarting again at 0.001\u20130.004\u00a0units/minute)", "Careful monitoring of fetal heart rate\r\nand uterine motility essential for dose titration (avoid intravenous injection during labour);\r\ndiscontinue immediately in uterine hyperactivity or fetal distress ", "Caesarean section, by slow intravenous injection immediately after delivery, 5\u00a0units", "Prevention of postpartum haemorrhage, after delivery\r\nof placenta, by slow intravenous injection, 5\u00a0units\r\n(if infusion used for induction or enhancement of labour, increase\r\nrate during third stage and for next few hours).", "Avoid rapid intravenous injection (may\r\ntransiently reduce blood pressure)", "Can be given in a dose of 10\u00a0units by intramuscular injection [unlicensed route] instead of oxytocin with ergometrine (Syntometrine\u00ae), see notes above", "Treatment of postpartum haemorrhage, by slow\r\nintravenous injection, 5\u00a0units (dose may be repeated), followed\r\nin severe cases by intravenous infusion of 40\u00a0units\r\nin 500\u00a0mL infusion fluid at a rate sufficient to control uterine atony", "Avoid rapid intravenous injection (may\r\ntransiently reduce blood pressure); prolonged administration, see\r\nwarning below", "Incomplete, inevitable, or missed miscarriage, by slow intravenous injection, 5\u00a0units followed if necessary by intravenous infusion, 0.02\u20130.04\u00a0units/minute or faster", "Prolonged intravenous administration\r\nat high doses with large volume of fluid (which is possible in inevitable\r\nor missed miscarriage or postpartum haemorrhage) may cause water intoxication\r\nwith hyponatraemia. To avoid: use electrolyte-containing\r\ndiluent (i.e. not glucose), increase oxytocin concentration to reduce fluid, restrict fluid intake by mouth; monitor\r\nfluid and electrolytes.", "Oxytocin doses in the BNF may differ from\r\nthose in the product literature"]}]